You pay monthly for as long as you want to continue the program
Research published in obesity and metabolic journals has documented that patients on GLP-1 therapies sometimes report reduced anxiety alongside weight loss
Notably, long-term effects of empaglifozin on renal and cardiovascular outcomes were assessed with the EMPA REG OUTCOME trial which demonstrated a reduction in the risk of death from cardiovascular disease (HR 0.62, 95% CI, 0.490.77), hospitalization for heart failure (HR 0.65, 95% CI, 0.500.85), and death from any cause (HR 0.68, 95% CI, 0.570.82) [97], as well as slower progression of kidney disease (HR 0.61, 95% CI, 0.53 to 0.70) and lower rates of clinically relevant renal events than placebo (HR 0.54, 95% CI, 0.400.75)
Visit Lemon Drop Med Spa at 22186 Market Place Drive Suite 120, New Caney TX 77357 to learn more and schedule an appointment.
When you eat, nutrients in your gut stimulate these L-cells to release GLP-1